Bnp Paribas Arbitrage, Snc »

Lyell Immunopharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-12-31 $98k 3.2k 30.78
2025-09-30 $5.8k 355 16.24
2025-06-30 $3.1k 353 8.84

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Amazon.com Equity (AMZN)
Meta Platforms Equity (META)
Tesla Equity (TSLA)
Alphabet Equity (GOOGL)
JPMorgan Chase & Co Equity (JPM)
Broadcom Equity (AVGO)
State Street SPDR S&P Biotech ETF Fund (XBI)
Alphabet Equity (GOOG)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Cisco Systems Equity (CSCO)
Micron Technology Equity (MU)
Advanced Micro Devices Equity (AMD)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Vanguard Group
Foresite Capital Management IV
Orland Properties
Almitas Capital
Foresite Capital Management V
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding
Millennium Management

View all funds holding Lyell Immunopharma